Skip Navigation


Europace Advance Access originally published online on April 8, 2009
Europace 2009 11(6):710-715; doi:10.1093/europace/eup091
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
11/6/710    most recent
eup091v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cevik, C.
Right arrow Articles by Nugent, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cevik, C.
Right arrow Articles by Nugent, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org

REVIEWS

Implantable cardioverter defibrillators and their role in heart failure progression

Cihan Cevik1,*, Alejandro Perez-Verdia2 and Kenneth Nugent1

1 Department of Internal Medicine, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX 79430, USA; 2 Cardiology Division, Texas Tech University Health Sciences Center, Lubbock, TX, USA

Patients with an implantable cardioverter defibrillator (ICD) implanted for primary prevention have an increased mortality rate if they receive appropriate and/or inappropriate ICD shocks. The most common cause of increased mortality is worsening heart failure. ICD shocks cause direct myocardial injury, contraction band necrosis, and fibrosis, and could induce persistent inflammation. These changes likely contribute to the ventricular dysfunction in patients who have a significantly depressed ejection fraction initially. One-third of the patients with ICDs have psychiatric disorders. Studies have demonstrated that the patients have decreased quality of life, including emotional dysfunction, during the month following an ICD shock. Patients with anxiety and depression have an activated hypothalamus–hypophysis–adrenal axis, increased sympathetic activity, and decreased vagal tone. Chronic sympathetic stimulation could directly affect the myocardium and worsen cardiac dysfunction. Consequently, although ICD implantation is life-saving, it may contribute to heart failure progression. Completed trials need reanalysis to determine whether there are unique characteristics of patients receiving shocks that might lead to additional therapy. Furthermore, the interaction between psychiatric disorders and ICD therapy needs more study.

Key Words: Implantable cardioverter defibrillator, Arrhythmia, Heart failure

* Corresponding author. Tel: +1 806 7433155, Fax: +1 806 7433148, Email: cihan.cevik{at}ttuhsc.edu

Manuscript submitted 24 February 2009. Accepted after revision 20 March 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.